BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11207259)

  • 1. Expression of a V region-less B cell receptor confers a tolerance-like phenotype on transgenic B cells.
    Corcos D; Grandien A; Vazquez A; Dunda O; Lorès P; Bucchini D
    J Immunol; 2001 Mar; 166(5):3083-9. PubMed ID: 11207259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors.
    Kenny JJ; Rezanka LJ; Lustig A; Fischer RT; Yoder J; Marshall S; Longo DL
    J Immunol; 2000 Apr; 164(8):4111-9. PubMed ID: 10754305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncation of the mu heavy chain alters BCR signalling and allows recruitment of CD5+ B cells.
    Zou X; Ayling C; Xian J; Piper TA; Barker PJ; Brüggemann M
    Int Immunol; 2001 Dec; 13(12):1489-99. PubMed ID: 11717190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic human lambda 5 rescues the murine lambda 5 nullizygous phenotype.
    Donohoe ME; Beck-Engeser GB; Lonberg N; Karasuyama H; Riley RL; Jäck HM; Blomberg BB
    J Immunol; 2000 May; 164(10):5269-76. PubMed ID: 10799888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains.
    Kline GH; Hartwell L; Beck-Engeser GB; Keyna U; Zaharevitz S; Klinman NR; Jäck HM
    J Immunol; 1998 Aug; 161(4):1608-18. PubMed ID: 9712022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing.
    Middendorp S; Hendriks RW
    J Immunol; 2004 Feb; 172(3):1371-9. PubMed ID: 14734712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa editing rescues autoreactive B cells destined for deletion in mice transgenic for a dual specific anti-laminin Ig.
    Brady GF; Congdon KL; Clark AG; Sackey FN; Rudolph EH; Radic MZ; Foster MH
    J Immunol; 2004 May; 172(9):5313-21. PubMed ID: 15100270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein.
    Litzenburger T; Blüthmann H; Morales P; Pham-Dinh D; Dautigny A; Wekerle H; Iglesias A
    J Immunol; 2000 Nov; 165(9):5360-6. PubMed ID: 11046072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal deletion of B cells expressing surface Ig molecules that lack V(D)J-encoded determinants in the bursa of Fabricius is not due to intrafollicular competition.
    Sayegh CE; Ratcliffe MJ
    J Immunol; 2000 May; 164(10):5041-8. PubMed ID: 10799859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive surface B cell antigen receptor down-regulation accompanies efficient development of antinuclear antigen B cells to mature, follicular phenotype.
    Heltemes-Harris L; Liu X; Manser T
    J Immunol; 2004 Jan; 172(2):823-33. PubMed ID: 14707052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negligible class II MHC presentation of B cell receptor-derived peptides by high density resting B cells.
    Snyder CM; Zhang X; Wysocki LJ
    J Immunol; 2002 Apr; 168(8):3865-73. PubMed ID: 11937540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.
    Shaffer AL; Schlissel MS
    J Immunol; 1997 Aug; 159(3):1265-75. PubMed ID: 9233622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-B-cell development in the absence of lambda 5 in transgenic mice expressing a heavy-chain disease protein.
    Corcos D; Dunda O; Butor C; Cesbron JY; Lorès P; Bucchini D; Jami J
    Curr Biol; 1995 Oct; 5(10):1140-8. PubMed ID: 8548286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo VL-targeted activation-induced apoptotic supraclonal deletion by a microbial B cell toxin.
    Goodyear CS; Narita M; Silverman GJ
    J Immunol; 2004 Mar; 172(5):2870-7. PubMed ID: 14978088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression of a human polyreactive Ig expressed in chronic lymphocytic leukemia generates memory-type B cells that respond to nonspecific immune activation.
    Widhopf GF; Brinson DC; Kipps TJ; Tighe H
    J Immunol; 2004 Feb; 172(4):2092-9. PubMed ID: 14764674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a ligand-mediated positive selection signal in differentiation to a mature B cell.
    Wang H; Clarke SH
    J Immunol; 2003 Dec; 171(12):6381-8. PubMed ID: 14662836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficiency of B cell receptor (BCR) editing is dependent on BCR light chain rearrangement status.
    Yachimovich N; Mostoslavsky G; Yarkoni Y; Verbovetski I; Eilat D
    Eur J Immunol; 2002 Apr; 32(4):1164-74. PubMed ID: 11932924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance through indifference: autoreactive B cells to the nuclear antigen La show no evidence of tolerance in a transgenic model.
    Aplin BD; Keech CL; de Kauwe AL; Gordon TP; Cavill D; McCluskey J
    J Immunol; 2003 Dec; 171(11):5890-900. PubMed ID: 14634099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic graft-versus-host in Ig knockin transgenic mice abrogates B cell tolerance in anti-double-stranded DNA B cells.
    Sekiguchi DR; Jainandunsing SM; Fields ML; Maldonado MA; Madaio MP; Erikson J; Weigert M; Eisenberg RA
    J Immunol; 2002 Apr; 168(8):4142-53. PubMed ID: 11937575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen.
    Duong BH; Ota T; Aït-Azzouzene D; Aoki-Ota M; Vela JL; Huber C; Walsh K; Gavin AL; Nemazee D
    J Immunol; 2010 Apr; 184(8):4143-58. PubMed ID: 20231687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.